Cargando…

Dalfampridine is associated with de novo occurrence or reoccurrence of positive sensory symptoms in MS

Detalles Bibliográficos
Autores principales:	Solaro, C., Trabucco, E., Messmer Uccelli, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818134/ https://www.ncbi.nlm.nih.gov/pubmed/29473053 http://dx.doi.org/10.1016/j.ensci.2015.11.003

Ejemplares similares

Clarification of Dalfampridine Labeled Indications
por: Rabinowicz, Adrian L., et al.
Publicado: (2012)

A Massive Overdose of Dalfampridine
por: Fil, Laura J., et al.
Publicado: (2015)

Dalfampridine effects on cognition, fatigue, and dexterity
por: Korsen, Melanie, et al.
Publicado: (2016)

Italian Validation of the 12-Item Multiple Sclerosis Walking Scale
por: Solaro, C., et al.
Publicado: (2015)

Identification of metabolites of dalfampridine (4-aminopyridine) in dog and rat
por: Caggiano, Anthony, et al.
Publicado: (2013)

Objective and subjective measures of dalfampridine efficacy in clinical practice
por: Klineova, Sylvia, et al.
Publicado: (2018)

Dalfampridine Prior Authorization Program: A Cohort Study
por: Gleason, Patrick P., et al.
Publicado: (2013)

De Novo Urinary Symptoms Associated With COVID-19: COVID-19-Associated Cystitis
por: Dhar, Nivedita, et al.
Publicado: (2020)

Acute shortness of breath due to reoccurrence of an intrapericardial bronchogenic cyst
por: Gimpel, Damian, et al.
Publicado: (2019)

Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
por: Fukuda, Yuko, et al.
Publicado: (2022)

Increasing Patient Safety Among Multiple Sclerosis (MS) Drug Dalfampridine Users by Expanding Awareness of the Serious Side Effects
por: Zaman, Rameez, et al.
Publicado: (2022)

Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation
por: Gajendra, Smeeta, et al.
Publicado: (2015)

Reoccurrence of Bleeding of a Chronic Subdural Haematoma Following a Fall
por: Carretero, Rafael García
Publicado: (2017)

Reoccurrence of Stroke in a Patient With Peri-Device Leak of WATCHMAN Device
por: Perkins, Jordan, et al.
Publicado: (2020)

Comment: In Response to “Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation”
por: Uz, Burak, et al.
Publicado: (2016)

Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis
por: Hayes, Keith C
Publicado: (2011)

Dalfampridine: Review of its Efficacy in Improving Gait in Patients with Multiple Sclerosis
por: Sahraian, M.A., et al.
Publicado: (2011)

Use of Dalfampridine in a Young Child with Episodic Ataxia Type 2
por: Malamud, Emily, et al.
Publicado: (2022)

Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure
por: MIZUNO, Masashi, et al.
Publicado: (2016)

Spontaneous reoccurrence of “scooping”, a wild tool-use behaviour, in naïve chimpanzees
por: Bandini, Elisa, et al.
Publicado: (2017)

Predictors of cerebrovascular event reoccurrence in patients with depression: a retrospective cohort study
por: Cai, Wa, et al.
Publicado: (2020)

Reoccurrence of Avian Influenza A(H5N2) Virus Clade 2.3.4.4 in Wild Birds, Alaska, USA, 2016
por: Lee, Dong-Hun, et al.
Publicado: (2017)

Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis
por: Jeffery, Douglas R, et al.
Publicado: (2010)

Oral Dalfampridine Improves Standing Balance Detected at Static Posturography in Multiple Sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US
por: Jara, Michele, et al.
Publicado: (2013)

Randomized, Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis
por: Schwartz, Kateryna, et al.
Publicado: (2017)

Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis
por: Shi, Jianzhen, et al.
Publicado: (2019)

Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials
por: Zhang, Enyao, et al.
Publicado: (2021)

Early reoccurrence of traumatic posterior atlantoaxial dislocation without fracture: A case report
por: Sun, Ying-Hua, et al.
Publicado: (2021)

Regulation of nitrogen dynamics at the sediment–water interface during HAB degradation and subsequent reoccurrence
por: Sima, Weiping, et al.
Publicado: (2020)

Clinical and epidemiological investigation of a child with asymptomatic COVID-19 infection following reoccurrence
por: Lin, Qiu‑Yu, et al.
Publicado: (2022)

Taste loss as the sole presenting symptom in Chinese patient with facial onset sensory and motor neuronopathy
por: Chen, Lu‐Xi, et al.
Publicado: (2021)

Doping May Be Responsible forDe Novo Mitochondrial Disorder
por: Finsterer, Josef
Publicado: (2019)

Discreet Monilethrix: De novo Mutation on the Example of Polish Families
por: Brzezinski, Piotr, et al.
Publicado: (2017)

Teriflunomide treatment reduces B cells in patients with MS
por: Gandoglia, Ilaria, et al.
Publicado: (2017)

Orthostatic Hypotension and Cognitive Impairment in De Novo Patients with Parkinson’s Disease
por: Bae, Hyo-Jin, et al.
Publicado: (2014)

Utility of Protocol Pancreas Biopsies for De Novo Donor-specific Antibodies
por: Parajuli, Sandesh, et al.
Publicado: (2022)

De novo vasculitis after mRNA-1273 (Moderna) vaccination
por: Anderegg, Manuel A., et al.
Publicado: (2021)

Reply: De novo mutations in CLDN5: alternating hemiplegia of childhood or not?
por: Desguerre, Isabelle, et al.
Publicado: (2023)

Reoccurrence of botulinum neurotoxin subtype A3 inducing food-borne botulism, Slovakia, 2015
por: Mad’arová, Lucia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lp88rqfgrpqpaql1airg1ij7fq